Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06289101 · ClinicalTrials.gov registry record · NA

text4FATHER R21: Social Media - Efficacy Trial

A NA study of Fathers and Mobile Health, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT06289101: Recruiting NA study of Fathers and Mobile Health, sponsored by Johns Hopkins University.

NCT06289101 is a NA study of Fathers and Mobile Health that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 180 participants, below the 360-participant average among 4 other Fathers trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06289101, a NA study of Fathers and Mobile Health, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

This project will be the first to examine the efficacy of a text messaging intervention designed to recruit first-time fathers-to-be using social media across the U.S. to become involved during pregnancy through two months of postnatal age to support infant, mother, and father well-being.

Primary Outcome

Self-report measure with higher score indicating greater confidence in overall parenting skills. This measure is scaled with range from 1 (low) to 6 (high). Mean range 1-6.

Interventions

  • BEHAVIORAL text4FATHER

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2024-09-10
Est. Completion 2026-08
Phase NA
Johns Hopkins University

1,448 total trials

What NCT06289101 shows while recruiting

NCT06289101 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 360-participant average among 4 other Fathers trials with a reported enrollment target (50% lower).

The record links to 3 conditions, with Fathers appearing as the primary indexed condition, and to 1 intervention - of which text4FATHER is the first listed.

NCT06289101 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06289101 about?

NCT06289101 is a clinical study titled "text4FATHER R21: Social Media - Efficacy Trial". This project will be the first to examine the efficacy of a text messaging intervention designed to recruit first-time fathers-to-be using social media across the U.S. to become involved during pregnancy through two months of postnatal age to support infant, mother, and father well-being.

What is the current status of trial NCT06289101?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-09-10. Estimated completion is 2026-08.

What conditions does trial NCT06289101 study?

This clinical trial studies the following conditions: Fathers, Mobile Health, Nuclear Family.

What interventions are being tested in trial NCT06289101?

The interventions under investigation include: text4FATHER (BEHAVIORAL).

Who is sponsoring clinical trial NCT06289101?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06289101 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fathers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06289101, the US trial registry maintained by the National Library of Medicine. NCT06289101 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.